Cargando…
Tenecteplase vs. alteplase for acute ischemic stroke: a systematic review
INTRODUCTION: Thrombolysis for acute ischemic stroke (AIS) with alteplase is the currently approved therapy for patients who present within 4.5 h of symptom onset and meet criteria. Recently, there has been interest in the thrombolytic tenecteplase, a modified version of alteplase, due to its lower...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903524/ https://www.ncbi.nlm.nih.gov/pubmed/34983359 http://dx.doi.org/10.1186/s12245-021-00399-w |